Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01249937
What this trial is testing

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT04895293
What this trial is testing

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 5
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01414153
What this trial is testing

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Lpath, Inc. 158
Testing effectiveness (Phase 2)Study completedNCT02022501
What this trial is testing

A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 10
Large-scale testing (Phase 3)Study completedNCT03954626
What this trial is testing

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

Who this might be right for
Age-Related Macular DegenerationMacular DegenerationWet Macular Degeneration+3 more
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT02903576
What this trial is testing

Stem Cell Therapy for Outer Retinal Degenerations

Who this might be right for
Age Related Macular DegenerationStargardt's DiseaseExudative Age-related Macular Degeneration
Federal University of São Paulo 15
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Not applicableStudy completedNCT03278262
What this trial is testing

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

Who this might be right for
Wet Macular Degeneration
Bayer 2,312
Not applicableStudy completedNCT01204541
What this trial is testing

A Single-Center Pilot Study to Assess Macular Function

Who this might be right for
Macular Degeneration
ORA, Inc. 24
Not applicableStudy completedNCT00927303
What this trial is testing

The Spectralis-Cirrus Study

Who this might be right for
Exudative Age Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 110
Testing effectiveness (Phase 2)Study completedNCT01849692
What this trial is testing

ESBA1008 Microvolume Study

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 107
Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Not applicableWithdrawnNCT00726973
What this trial is testing

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Edema
Lahey Clinic
Early research (Phase 1)Study completedNCT00725686
What this trial is testing

Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)

Who this might be right for
Age-Related Macular Degeneration
Quark Pharmaceuticals 54
Not applicableUnknownNCT02328209
What this trial is testing

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Mie University 50
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Not applicableStudy completedNCT05211804
What this trial is testing

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

Who this might be right for
Wet Macular Degeneration
Sorlandet Hospital HF 31
Next Page